Get the Stockscreener App
186.81
0.95%
1.83
Irhythm Technologies Inc stock is traded at $186.81, with a volume of 207.08K.
It is up +0.95% in the last 24 hours and up +4.69% over the past month.
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.
See More
Previous Close:
$184.98
Open:
$186.06
24h Volume:
207.08K
Relative Volume:
0.49
Market Cap:
$6.01B
Revenue:
$560.03M
Net Income/Loss:
$-150.66M
P/E Ratio:
-38.44
EPS:
-4.86
Net Cash Flow:
$-87.43M
1W Performance:
+5.24%
1M Performance:
+4.69%
6M Performance:
+34.13%
1Y Performance:
+106.18%
1-Day Range:
$184.84
$191.40
1-Week Range:
$173.46
$191.40
52-Week Range:
$86.99
$212.00
Irhythm Technologies Inc Stock (IRTC) Company Profile
Name
Irhythm Technologies Inc
Sector
Industry
Phone
415-632-5700
Address
699 8TH STREET, San Francisco, CA
Compare IRTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IRTC
Irhythm Technologies Inc
|
186.57 | 5.96B | 560.03M | -150.66M | -87.43M | -4.86 |
|
ABT
Abbott Laboratories
|
127.09 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.67 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.80 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.67 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Irhythm Technologies Inc Stock (IRTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-23-25 | Initiated | Evercore ISI | In-line |
| Aug-20-25 | Initiated | BofA Securities | Buy |
| May-02-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-03-24 | Resumed | Wells Fargo | Equal Weight |
| Oct-04-24 | Initiated | Goldman | Neutral |
| Jun-20-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Dec-11-23 | Upgrade | Citigroup | Neutral → Buy |
| Jul-19-23 | Initiated | Robert W. Baird | Outperform |
| Feb-07-23 | Initiated | Wells Fargo | Overweight |
| Nov-07-22 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jun-09-22 | Downgrade | Citigroup | Buy → Neutral |
| Apr-06-22 | Initiated | Wolfe Research | Underperform |
| Feb-24-22 | Upgrade | Needham | Hold → Buy |
| Jan-18-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-12-22 | Upgrade | BTIG Research | Neutral → Buy |
| Jan-11-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Dec-21-21 | Resumed | Canaccord Genuity | Buy |
| Dec-17-21 | Upgrade | JP Morgan | Neutral → Overweight |
| Dec-15-21 | Upgrade | Citigroup | Neutral → Buy |
| Jun-02-21 | Downgrade | Citigroup | Buy → Neutral |
| Apr-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-12-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-26-21 | Downgrade | Colliers Securities | Buy → Neutral |
| Jan-29-21 | Reiterated | Needham | Hold |
| Nov-17-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Sep-11-20 | Initiated | Needham | Hold |
| Sep-02-20 | Initiated | Robert W. Baird | Neutral |
| Aug-07-20 | Upgrade | Colliers Securities | Neutral → Buy |
| Aug-05-20 | Upgrade | Oppenheimer | Perform → Outperform |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jan-10-20 | Initiated | William Blair | Outperform |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Oct-22-19 | Initiated | Oppenheimer | Perform |
| Feb-20-19 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Sep-13-18 | Reiterated | Canaccord Genuity | Buy |
| Sep-06-18 | Initiated | Chardan Capital Markets | Buy |
| Aug-02-18 | Upgrade | Dougherty & Company | Sell → Neutral |
| Jul-16-18 | Downgrade | Dougherty & Company | Neutral → Sell |
| Dec-01-17 | Initiated | Dougherty & Company | Neutral |
View All
Irhythm Technologies Inc Stock (IRTC) Latest News
Will iRhythm Technologies Inc. stock continue upward momentum2026 world cup usa national team semifinals goalkeepers transition play expert forecast insights - ulpravda.ru
Risks To Shareholder Returns Are Elevated At These Prices For IRhythm Technologies, Inc. (NASDAQ:IRTC) - 富途牛牛
Evercore ISI Group Upgrades iRhythm Technologies (IRTC) - Nasdaq
Why iRhythm Technologies Inc stock is seen as undervaluedEarnings Beat & Technical Confirmation Alerts - moha.gov.vn
Evercore ISI Group Upgrades iRhythm Technologies (IRTC) Rating, Raises Price Target | IRTC Stock News - GuruFocus
How Recent Developments Are Reframing The Story For iRhythm Technologies (IRTC) - Yahoo Finance
How Irhythm Technologies Inc. (IRTC) Affects Rotational Strategy Timing - Stock Traders Daily
Allspring Global Investments Holdings LLC Sells 18,826 Shares of iRhythm Technologies $IRTC - MarketBeat
iRhythm Technologies $IRTC Stock Position Raised by Osaic Holdings Inc. - MarketBeat
iRhythm Technologies (NASDAQ:IRTC) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
iRhythm Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Turakhia Joins iRhythm for Planned Leave of Absence - Stanford Medicine
Harbor Capital Advisors Inc. Has $1.55 Million Position in iRhythm Technologies $IRTC - MarketBeat
Inspire Investing LLC Makes New Investment in iRhythm Technologies $IRTC - MarketBeat
Ecg Sensor Patch Market 2025-2032: Growth Overview, Facts & - openPR.com
Morgan Stanley raises iRhythm (IRTC) PT on MedTech recovery outlook - MSN
iRhythm Technologies Earnings Notes - Trefis
Does iRhythm Technologies (IRTC) Asia-Pacific Data Shift Its Competitive Edge in Cardiac Monitoring? - Sahm
Why iRhythm (IRTC) Stock Is Up Today - Finviz
Morgan Stanley Raises iRhythm (IRTC) PT on MedTech Recovery Outlook - Finviz
11 Best Healthcare AI Stocks to Buy Now - Insider Monkey
Will iRhythm Technologies Inc. stock benefit from infrastructure spendingExit Point & Daily Volume Surge Signals - Улправда
(IRTC) Risk Channels and Responsive Allocation - Stock Traders Daily
Profit Review: Why iRhythm Technologies Inc. stock could benefit from AI revolution - Улправда
Can iRhythm Technologies Inc. stock continue upward trendTrade Volume Report & Free Long-Term Investment Growth Plans - Улправда
Why iRhythm Technologies Inc. stock could benefit from AI revolution2025 Technical Overview & Community Verified Watchlist Alerts - Улправда
Assenagon Asset Management S.A. Invests $13.39 Million in iRhythm Technologies $IRTC - MarketBeat
How analysts revise price targets for iRhythm Technologies Inc. (I25) stockMarket Volume Summary & Daily Technical Forecast Reports - Улправда
Market Overview: How analysts revise price targets for iRhythm Technologies Inc. (I25) stock2025 Top Decliners & Target Return Focused Picks - Улправда
Is iRhythm Technologies Inc. stock a buy before product launches2025 Short Interest & Detailed Earnings Play Alerts - Улправда
Can iRhythm Technologies Inc. stock rebound after recent weaknessMarket Activity Report & Growth Focused Investment Plans - Улправда
Options Flow: How sustainable is iRhythm Technologies Inc. stock dividend payoutMarket Sentiment Report & Daily Stock Trend Watchlist - Улправда
Exit Recap: Will iRhythm Technologies Inc. stock benefit from infrastructure spendingJuly 2025 Reactions & Weekly Top Stock Performers List - Улправда
Why iRhythm Technologies Inc. stock could see breakout soonQuarterly Profit Review & Long-Term Growth Portfolio Plans - DonanımHaber
Is iRhythm Technologies Inc. stock a contrarian buyMarket Activity Report & Verified Stock Trade Ideas - DonanımHaber
Is iRhythm Technologies Inc. stock recession proofEarnings Recap Report & Precise Trade Entry Recommendations - DonanımHaber
Rate Hike: Why iRhythm Technologies Inc. stock could benefit from AI revolution2025 Market Trends & Technical Pattern Based Signals - Улправда
iRhythm Technologies Inc buy Truist Financial Co. - sharewise.com
Truist Securities Lowers Price Target for iRhythm Technologies (IRTC) | IRTC Stock News - GuruFocus
iRhythm Technologies (NASDAQ:IRTC) Price Target Lowered to $215.00 at Truist Financial - MarketBeat
Truist Securities Adjusts Price Target on iRhythm Technologies to $215 From $230, Maintains Buy Rating - marketscreener.com
iRhythm Technologies (IRTC) Leads Cardiac Monitoring Market with Zio Device, Freedom Capital Initiates Coverage - MSN
Robert W. Baird Remains a Buy on Irhythm Technologies (IRTC) - The Globe and Mail
IRhythm Technologies, Inc.'s (NASDAQ:IRTC) Profit Outlook - 富途牛牛
Free cash flow per share of iRhythm Technologies, Inc. – GETTEX:I25 - TradingView — Track All Markets
Cim Investment Management Inc. Sells 5,929 Shares of iRhythm Technologies $IRTC - MarketBeat
Eventide Asset Management LLC Has $106.48 Million Stock Holdings in iRhythm Technologies $IRTC - MarketBeat
Goldman Sachs Maintains iRhythm Technologies (IRTC) Neutral Recommendation - MSN
Frontier Capital Management Co. LLC Decreases Stock Position in iRhythm Technologies $IRTC - MarketBeat
Federated Hermes Inc. Invests $7.46 Million in iRhythm Technologies $IRTC - MarketBeat
Natixis Purchases 17,500 Shares of iRhythm Technologies $IRTC - MarketBeat
Irhythm Technologies Inc Stock (IRTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.20%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):